6-mercaptopurine beats a bum rap.

[1]  J. Lewis,et al.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.

[2]  C. Bodian,et al.  The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. , 2003, Gastroenterology.

[3]  J. Markowitz.  Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. , 2003, Reviews in gastroenterological disorders.

[4]  D. Jewell,et al.  Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine , 2002, Alimentary pharmacology & therapeutics.

[5]  Dermot Kelleher,et al.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low , 2000, Gut.

[6]  J. Schwartz,et al.  Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. , 2000, Gastroenterology.

[7]  G. Fick,et al.  Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.

[8]  W. Connell,et al.  Treating Inflammatory Bowel Disease During Pregnancy , 1999, Drug safety.

[9]  M. Kamm,et al.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease , 1994, The Lancet.

[10]  M. Kamm,et al.  Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. , 1993, Gut.

[11]  S. Meltzer,et al.  6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. , 1989, Annals of internal medicine.

[12]  D. Present,et al.  Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial. , 1981, Gastroenterology.

[13]  R. Summers,et al.  National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.

[14]  F. Rosner,et al.  Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. , 1979, Archives of internal medicine.

[15]  E. Swarbrick,et al.  Azathioprine for Crohn's disease. , 1969, Lancet.